(DGS) WisdomTree Emerging Markets - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US97717W2816
DGS: Small Cap, Emerging Markets, Dividend-Focused
The WisdomTree Emerging Markets SmallCap Dividend Fund (DGS) is an exchange-traded fund that focuses on investing in small-cap dividend-paying stocks from emerging markets. Under normal circumstances, the fund allocates at least 95% of its total assets to constituent securities of its underlying index, as well as investments with similar economic characteristics. This underlying index is fundamentally weighted, comprising small-cap common stocks selected from the broader WisdomTree Emerging Markets Dividend Index.
As a non-diversified fund, DGS may have a higher concentration of assets in a smaller number of holdings, which can increase its volatility compared to diversified funds. The funds investment strategy is centered around dividend-paying stocks, which can provide a relatively stable source of returns, particularly in emerging markets where dividend yields can be attractive.
Analyzing the funds technical data, we observe that the last price is $54.16, slightly above its 20-day Simple Moving Average (SMA) of $53.48, indicating a positive short-term trend. The 50-day and 200-day SMAs are $50.64 and $50.29, respectively, suggesting a longer-term uptrend. The Average True Range (ATR) is $0.50, or 0.92%, indicating moderate volatility. Given these technical indicators, we can forecast that DGS may continue its upward trend, potentially testing its 52-week high of $54.95 in the near term, provided the overall market conditions remain favorable.
From a fundamental perspective, the funds Assets Under Management (AUM) stand at $1.622 billion USD, indicating a sizable presence in the market. Considering the current dividend-focused investment landscape and the attractiveness of emerging markets, we can anticipate that DGS will continue to attract investors seeking exposure to dividend-paying stocks in emerging markets. Combining this with the technical analysis, our forecast suggests that DGS could potentially reach $56.00 in the next few months, driven by its positive trend and the appeal of dividend stocks in emerging markets.
Additional Sources for DGS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
DGS ETF Overview
Market Cap in USD | 1,612m |
Category | Diversified Emerging Mkts |
TER | 0.58% |
IPO / Inception | 2007-10-30 |
DGS ETF Ratings
Growth Rating | 50.0 |
Fundamental | - |
Dividend Rating | 30.1 |
Rel. Strength | -4.1 |
Analysts | - |
Fair Price Momentum | 52.76 USD |
Fair Price DCF | - |
DGS Dividends
Dividend Yield 12m | 1.89% |
Yield on Cost 5y | 3.11% |
Annual Growth 5y | -1.35% |
Payout Consistency | 89.3% |
Payout Ratio | % |
DGS Growth Ratios
Growth Correlation 3m | 96% |
Growth Correlation 12m | -8.5% |
Growth Correlation 5y | 71.9% |
CAGR 5y | 11.51% |
CAGR/Max DD 5y | 0.46 |
Sharpe Ratio 12m | 1.41 |
Alpha | 0.73 |
Beta | 0.566 |
Volatility | 13.93% |
Current Volume | 80.4k |
Average Volume 20d | 135.7k |
As of June 30, 2025, the stock is trading at USD 54.86 with a total of 80,422 shares traded.
Over the past week, the price has changed by +2.80%, over one month by +3.72%, over three months by +14.65% and over the past year by +9.48%.
Partly, yes. Based on ValueRay´s Analyses, WisdomTree Emerging Markets (NYSE ARCA:DGS) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 49.99 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DGS is around 52.76 USD . This means that DGS is currently overvalued and has a potential downside of -3.83%.
WisdomTree Emerging Markets has no consensus analysts rating.
According to our own proprietary Forecast Model, DGS WisdomTree Emerging Markets will be worth about 59.4 in June 2026. The stock is currently trading at 54.86. This means that the stock has a potential upside of +8.22%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 59.4 | 8.2% |